atrial-natriuretic-factor and Remission--Spontaneous

atrial-natriuretic-factor has been researched along with Remission--Spontaneous* in 3 studies

Other Studies

3 other study(ies) available for atrial-natriuretic-factor and Remission--Spontaneous

ArticleYear
Clinical, echocardiographic, and hormonal factors influencing spontaneous conversion of recent-onset atrial fibrillation to sinus rhythm.
    The American journal of cardiology, 2000, Aug-01, Volume: 86, Issue:3

    The present study was designed to determine clinical, hormonal, and echocardiographic factors influencing spontaneous conversion to sinus rhythm of recent-onset atrial fibrillation (symptoms <6 hours). The most important predictor of spontaneous conversion was the time of onset of atrial fibrillation; patients who developed the arrhythmia during sleep had the highest probability of spontaneous conversion during the first 24 hours. A second predictor was the plasma concentration of atrial natriuretic peptide during the arrhythmia.

    Topics: Adult; Aged; Atrial Fibrillation; Atrial Function, Left; Atrial Natriuretic Factor; Circadian Rhythm; Echocardiography; Echocardiography, Doppler, Color; Electric Countershock; Female; Humans; Male; Middle Aged; Prognosis; Remission, Spontaneous

2000
Pathogenesis of edema formation in the nephrotic syndrome.
    Kidney international. Supplement, 1997, Volume: 58

    Topics: Adolescent; Aldosterone; Atrial Natriuretic Factor; Blood Volume; Child; Child, Preschool; Disease Progression; Edema; Humans; Kidney Function Tests; Nephrotic Syndrome; Osmotic Pressure; Remission, Spontaneous; Renin; Serum Albumin; Sodium

1997
Increased atrial natriuretic peptide in the nephrotic syndrome. Relationship to the renal function and the renin-angiotensin-aldosterone system.
    Scandinavian journal of clinical and laboratory investigation, 1988, Volume: 48, Issue:2

    Atrial natriuretic peptide (ANP), angiotensin II (Ang II), and aldosterone (Aldo) in plasma and creatinine clearance (Ccr) were determined during basal conditions in 17 patients with the nephrotic syndrome and 20 control subjects. In addition, six of the patients were studied after seven remissions of the syndrome. In the nephrotic syndrome ANP was higher than in the control group (9.7 (median) versus 7.2 pmol/l, p less than 0.01), Ccr was lower (55 versus 99 ml/min, p less than 0.01). Angiotensin II and Aldo were the same in patients and control subjects. After remission of the syndrome ANP was reduced (11.2 to 5.4 pmol/l, n = 7, p less than 0.02) and Ccr increased (52 to 84 ml/min, n = 7, p less than 0.02), whereas Ang II and Aldo were unchanged. A significant, negative correlation was found between ANP and Ccr in the subgroup of patients in whom the syndrome remitted (Q = -0.547, n = 14, p less than 0.05). Atrial natriuretic peptide was not correlated to either Ang II or Aldo in either of the groups. It is concluded that patients with the nephrotic syndrome have elevated ANP, and it is suggested that a high ANP may be a compensatory phenomenon induced by a decreased renal ability to eliminate sodium and water.

    Topics: Adult; Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Creatinine; Female; Humans; Male; Middle Aged; Nephrotic Syndrome; Remission, Spontaneous; Renin-Angiotensin System

1988